nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—melanoma	0.766	1	CbGaD
Trisalicylate-choline—Skin papilloma—Vemurafenib—melanoma	0.0116	0.0835	CcSEcCtD
Trisalicylate-choline—Localized exfoliation—Bleomycin—melanoma	0.00852	0.0612	CcSEcCtD
Trisalicylate-choline—PTGS2—leg—melanoma	0.00522	0.162	CbGeAlD
Trisalicylate-choline—PTGS2—hindlimb—melanoma	0.00466	0.145	CbGeAlD
Trisalicylate-choline—PTGS2—appendage—melanoma	0.004	0.124	CbGeAlD
Trisalicylate-choline—PTGS2—skin epidermis—melanoma	0.00332	0.104	CbGeAlD
Trisalicylate-choline—Burning sensation—Carmustine—melanoma	0.00288	0.0207	CcSEcCtD
Trisalicylate-choline—Stupor—Carmustine—melanoma	0.00268	0.0193	CcSEcCtD
Trisalicylate-choline—Duodenal ulcer—Docetaxel—melanoma	0.00266	0.0191	CcSEcCtD
Trisalicylate-choline—PTGS1—endothelium—melanoma	0.00252	0.0786	CbGeAlD
Trisalicylate-choline—PTGS2—endothelium—melanoma	0.00241	0.0751	CbGeAlD
Trisalicylate-choline—Hypocalcaemia—Dactinomycin—melanoma	0.00234	0.0168	CcSEcCtD
Trisalicylate-choline—PTGS1—blood vessel—melanoma	0.00233	0.0725	CbGeAlD
Trisalicylate-choline—PTGS2—blood vessel—melanoma	0.00222	0.0693	CbGeAlD
Trisalicylate-choline—Skin exfoliation—Bleomycin—melanoma	0.00219	0.0157	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Temozolomide—melanoma	0.00203	0.0146	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Carmustine—melanoma	0.00199	0.0143	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Dactinomycin—melanoma	0.00195	0.0141	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Carmustine—melanoma	0.00193	0.0139	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Carmustine—melanoma	0.00191	0.0137	CcSEcCtD
Trisalicylate-choline—Heartburn—Docetaxel—melanoma	0.00187	0.0134	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Temozolomide—melanoma	0.00187	0.0134	CcSEcCtD
Trisalicylate-choline—Burning sensation—Docetaxel—melanoma	0.00185	0.0133	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Temozolomide—melanoma	0.00185	0.0133	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Vemurafenib—melanoma	0.0018	0.0129	CcSEcCtD
Trisalicylate-choline—Erythema—Vemurafenib—melanoma	0.00166	0.0119	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Vemurafenib—melanoma	0.00162	0.0117	CcSEcCtD
Trisalicylate-choline—Lethargy—Dactinomycin—melanoma	0.00158	0.0114	CcSEcCtD
Trisalicylate-choline—Deafness—Temozolomide—melanoma	0.00157	0.0113	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Docetaxel—melanoma	0.00135	0.00972	CcSEcCtD
Trisalicylate-choline—Magnesium salicylate—PTGS2—melanoma	0.00135	0.365	CrCbGaD
Trisalicylate-choline—Injection site reaction—Docetaxel—melanoma	0.00128	0.0092	CcSEcCtD
Trisalicylate-choline—Hypotension—Vemurafenib—melanoma	0.00126	0.00908	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Docetaxel—melanoma	0.00123	0.00883	CcSEcCtD
Trisalicylate-choline—Magnesium salicylate—ALB—melanoma	0.0012	0.325	CrCbGaD
Trisalicylate-choline—Oesophagitis—Docetaxel—melanoma	0.00118	0.00845	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Vemurafenib—melanoma	0.00117	0.00844	CcSEcCtD
Trisalicylate-choline—Constipation—Vemurafenib—melanoma	0.00116	0.00831	CcSEcCtD
Trisalicylate-choline—Lightheadedness—Docetaxel—melanoma	0.00115	0.00828	CcSEcCtD
Trisalicylate-choline—Salsalate—PTGS2—melanoma	0.00114	0.31	CrCbGaD
Trisalicylate-choline—Weight increased—Temozolomide—melanoma	0.0011	0.00794	CcSEcCtD
Trisalicylate-choline—PTGS1—skin of body—melanoma	0.00108	0.0336	CbGeAlD
Trisalicylate-choline—Hepatitis—Dactinomycin—melanoma	0.00107	0.00772	CcSEcCtD
Trisalicylate-choline—Flushing—Bleomycin—melanoma	0.00107	0.00769	CcSEcCtD
Trisalicylate-choline—Deafness—Docetaxel—melanoma	0.00104	0.00751	CcSEcCtD
Trisalicylate-choline—PTGS2—skin of body—melanoma	0.00103	0.0321	CbGeAlD
Trisalicylate-choline—Erythema multiforme—Dactinomycin—melanoma	0.00102	0.0073	CcSEcCtD
Trisalicylate-choline—Erythema—Bleomycin—melanoma	0.001	0.00721	CcSEcCtD
Trisalicylate-choline—Hallucination—Carmustine—melanoma	0.001	0.00719	CcSEcCtD
Trisalicylate-choline—Flushing—Dactinomycin—melanoma	0.000997	0.00717	CcSEcCtD
Trisalicylate-choline—PTGS1—mammalian vulva—melanoma	0.000983	0.0306	CbGeAlD
Trisalicylate-choline—Hepatitis—Temozolomide—melanoma	0.000972	0.00699	CcSEcCtD
Trisalicylate-choline—Hallucination—Temozolomide—melanoma	0.000967	0.00695	CcSEcCtD
Trisalicylate-choline—Pruritus—Vemurafenib—melanoma	0.000956	0.00687	CcSEcCtD
Trisalicylate-choline—Lethargy—Docetaxel—melanoma	0.000953	0.00685	CcSEcCtD
Trisalicylate-choline—Erythema—Dactinomycin—melanoma	0.000935	0.00672	CcSEcCtD
Trisalicylate-choline—Flushing—Carmustine—melanoma	0.000933	0.00671	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Vemurafenib—melanoma	0.000924	0.00665	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Temozolomide—melanoma	0.000919	0.00661	CcSEcCtD
Trisalicylate-choline—Tinnitus—Temozolomide—melanoma	0.000906	0.00651	CcSEcCtD
Trisalicylate-choline—Flushing—Temozolomide—melanoma	0.000902	0.00648	CcSEcCtD
Trisalicylate-choline—Dizziness—Vemurafenib—melanoma	0.000893	0.00642	CcSEcCtD
Trisalicylate-choline—Erythema—Carmustine—melanoma	0.000875	0.00629	CcSEcCtD
Trisalicylate-choline—Vomiting—Vemurafenib—melanoma	0.000859	0.00618	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Docetaxel—melanoma	0.000853	0.00613	CcSEcCtD
Trisalicylate-choline—Rash—Vemurafenib—melanoma	0.000852	0.00612	CcSEcCtD
Trisalicylate-choline—Dermatitis—Vemurafenib—melanoma	0.000851	0.00612	CcSEcCtD
Trisalicylate-choline—Headache—Vemurafenib—melanoma	0.000846	0.00608	CcSEcCtD
Trisalicylate-choline—Erythema—Temozolomide—melanoma	0.000846	0.00608	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Temozolomide—melanoma	0.000828	0.00596	CcSEcCtD
Trisalicylate-choline—Confusional state—Bleomycin—melanoma	0.000825	0.00593	CcSEcCtD
Trisalicylate-choline—Oedema—Bleomycin—melanoma	0.000818	0.00588	CcSEcCtD
Trisalicylate-choline—Nausea—Vemurafenib—melanoma	0.000802	0.00577	CcSEcCtD
Trisalicylate-choline—Anorexia—Bleomycin—melanoma	0.00078	0.00561	CcSEcCtD
Trisalicylate-choline—Hypotension—Bleomycin—melanoma	0.000765	0.0055	CcSEcCtD
Trisalicylate-choline—Oedema—Dactinomycin—melanoma	0.000763	0.00549	CcSEcCtD
Trisalicylate-choline—Weight increased—Docetaxel—melanoma	0.000735	0.00528	CcSEcCtD
Trisalicylate-choline—Anorexia—Dactinomycin—melanoma	0.000728	0.00523	CcSEcCtD
Trisalicylate-choline—Confusional state—Carmustine—melanoma	0.00072	0.00518	CcSEcCtD
Trisalicylate-choline—Oedema—Carmustine—melanoma	0.000714	0.00514	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Bleomycin—melanoma	0.000711	0.00512	CcSEcCtD
Trisalicylate-choline—PTGS1—head—melanoma	0.000703	0.0219	CbGeAlD
Trisalicylate-choline—Pain—Bleomycin—melanoma	0.0007	0.00503	CcSEcCtD
Trisalicylate-choline—Confusional state—Temozolomide—melanoma	0.000696	0.00501	CcSEcCtD
Trisalicylate-choline—Oedema—Temozolomide—melanoma	0.00069	0.00496	CcSEcCtD
Trisalicylate-choline—Anorexia—Carmustine—melanoma	0.000681	0.0049	CcSEcCtD
Trisalicylate-choline—Epistaxis—Docetaxel—melanoma	0.000679	0.00488	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Bleomycin—melanoma	0.000674	0.00485	CcSEcCtD
Trisalicylate-choline—PTGS2—head—melanoma	0.000672	0.0209	CbGeAlD
Trisalicylate-choline—Hypotension—Carmustine—melanoma	0.000668	0.0048	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Temozolomide—melanoma	0.000667	0.0048	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Dactinomycin—melanoma	0.000664	0.00477	CcSEcCtD
Trisalicylate-choline—Anorexia—Temozolomide—melanoma	0.000658	0.00473	CcSEcCtD
Trisalicylate-choline—Pain—Dactinomycin—melanoma	0.000653	0.00469	CcSEcCtD
Trisalicylate-choline—Urticaria—Bleomycin—melanoma	0.00065	0.00467	CcSEcCtD
Trisalicylate-choline—Hepatitis—Docetaxel—melanoma	0.000646	0.00465	CcSEcCtD
Trisalicylate-choline—Somnolence—Carmustine—melanoma	0.000635	0.00457	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Dactinomycin—melanoma	0.000629	0.00452	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Carmustine—melanoma	0.000621	0.00447	CcSEcCtD
Trisalicylate-choline—Somnolence—Temozolomide—melanoma	0.000614	0.00441	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Docetaxel—melanoma	0.000611	0.00439	CcSEcCtD
Trisalicylate-choline—Constipation—Carmustine—melanoma	0.000611	0.00439	CcSEcCtD
Trisalicylate-choline—Pain—Carmustine—melanoma	0.000611	0.00439	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Temozolomide—melanoma	0.000608	0.00437	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Temozolomide—melanoma	0.0006	0.00432	CcSEcCtD
Trisalicylate-choline—Flushing—Docetaxel—melanoma	0.0006	0.00431	CcSEcCtD
Trisalicylate-choline—Pain—Temozolomide—melanoma	0.00059	0.00424	CcSEcCtD
Trisalicylate-choline—Constipation—Temozolomide—melanoma	0.00059	0.00424	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Carmustine—melanoma	0.000589	0.00423	CcSEcCtD
Trisalicylate-choline—Pruritus—Bleomycin—melanoma	0.000579	0.00416	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Temozolomide—melanoma	0.000569	0.00409	CcSEcCtD
Trisalicylate-choline—Erythema—Docetaxel—melanoma	0.000563	0.00404	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Docetaxel—melanoma	0.000551	0.00396	CcSEcCtD
Trisalicylate-choline—Urticaria—Temozolomide—melanoma	0.000548	0.00394	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Dactinomycin—melanoma	0.000522	0.00376	CcSEcCtD
Trisalicylate-choline—Vomiting—Bleomycin—melanoma	0.00052	0.00374	CcSEcCtD
Trisalicylate-choline—Rash—Bleomycin—melanoma	0.000516	0.00371	CcSEcCtD
Trisalicylate-choline—Dermatitis—Bleomycin—melanoma	0.000516	0.00371	CcSEcCtD
Trisalicylate-choline—PTGS1—lymph node—melanoma	0.000492	0.0153	CbGeAlD
Trisalicylate-choline—Diarrhoea—Carmustine—melanoma	0.000489	0.00351	CcSEcCtD
Trisalicylate-choline—Pruritus—Temozolomide—melanoma	0.000488	0.00351	CcSEcCtD
Trisalicylate-choline—Nausea—Bleomycin—melanoma	0.000486	0.0035	CcSEcCtD
Trisalicylate-choline—Vomiting—Dactinomycin—melanoma	0.000485	0.00349	CcSEcCtD
Trisalicylate-choline—Rash—Dactinomycin—melanoma	0.000481	0.00346	CcSEcCtD
Trisalicylate-choline—Dizziness—Carmustine—melanoma	0.000472	0.0034	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Temozolomide—melanoma	0.000472	0.0034	CcSEcCtD
Trisalicylate-choline—PTGS2—lymph node—melanoma	0.00047	0.0147	CbGeAlD
Trisalicylate-choline—Confusional state—Docetaxel—melanoma	0.000463	0.00333	CcSEcCtD
Trisalicylate-choline—Oedema—Docetaxel—melanoma	0.000459	0.0033	CcSEcCtD
Trisalicylate-choline—Dizziness—Temozolomide—melanoma	0.000457	0.00328	CcSEcCtD
Trisalicylate-choline—Vomiting—Carmustine—melanoma	0.000454	0.00327	CcSEcCtD
Trisalicylate-choline—Nausea—Dactinomycin—melanoma	0.000453	0.00326	CcSEcCtD
Trisalicylate-choline—Shock—Docetaxel—melanoma	0.000452	0.00325	CcSEcCtD
Trisalicylate-choline—Rash—Carmustine—melanoma	0.00045	0.00324	CcSEcCtD
Trisalicylate-choline—Dermatitis—Carmustine—melanoma	0.00045	0.00324	CcSEcCtD
Trisalicylate-choline—Headache—Carmustine—melanoma	0.000448	0.00322	CcSEcCtD
Trisalicylate-choline—Vomiting—Temozolomide—melanoma	0.000439	0.00316	CcSEcCtD
Trisalicylate-choline—Anorexia—Docetaxel—melanoma	0.000438	0.00315	CcSEcCtD
Trisalicylate-choline—Rash—Temozolomide—melanoma	0.000435	0.00313	CcSEcCtD
Trisalicylate-choline—Dermatitis—Temozolomide—melanoma	0.000435	0.00313	CcSEcCtD
Trisalicylate-choline—Headache—Temozolomide—melanoma	0.000433	0.00311	CcSEcCtD
Trisalicylate-choline—Hypotension—Docetaxel—melanoma	0.000429	0.00308	CcSEcCtD
Trisalicylate-choline—Nausea—Carmustine—melanoma	0.000424	0.00305	CcSEcCtD
Trisalicylate-choline—Nausea—Temozolomide—melanoma	0.00041	0.00295	CcSEcCtD
Trisalicylate-choline—Somnolence—Docetaxel—melanoma	0.000408	0.00293	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Docetaxel—melanoma	0.000404	0.00291	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Docetaxel—melanoma	0.000399	0.00287	CcSEcCtD
Trisalicylate-choline—Constipation—Docetaxel—melanoma	0.000393	0.00282	CcSEcCtD
Trisalicylate-choline—Pain—Docetaxel—melanoma	0.000393	0.00282	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Docetaxel—melanoma	0.000378	0.00272	CcSEcCtD
Trisalicylate-choline—Pruritus—Docetaxel—melanoma	0.000325	0.00234	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Docetaxel—melanoma	0.000314	0.00226	CcSEcCtD
Trisalicylate-choline—Dizziness—Docetaxel—melanoma	0.000304	0.00218	CcSEcCtD
Trisalicylate-choline—Vomiting—Docetaxel—melanoma	0.000292	0.0021	CcSEcCtD
Trisalicylate-choline—Rash—Docetaxel—melanoma	0.000289	0.00208	CcSEcCtD
Trisalicylate-choline—Dermatitis—Docetaxel—melanoma	0.000289	0.00208	CcSEcCtD
Trisalicylate-choline—Headache—Docetaxel—melanoma	0.000288	0.00207	CcSEcCtD
Trisalicylate-choline—Nausea—Docetaxel—melanoma	0.000273	0.00196	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—NRAS—melanoma	0.000157	0.00265	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PTGS2—melanoma	0.000152	0.00255	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—melanoma	0.00015	0.00252	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000149	0.00251	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—RAC1—melanoma	0.000148	0.0025	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—MYC—melanoma	0.000147	0.00247	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	0.000143	0.00241	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—EGFR—melanoma	0.000143	0.00241	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000142	0.00239	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CDK2—melanoma	0.000141	0.00237	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000139	0.00235	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ALB—melanoma	0.000138	0.00232	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—TNF—melanoma	0.000136	0.0023	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TLR4—melanoma	0.000136	0.00229	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—KRAS—melanoma	0.000135	0.00228	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN2A—melanoma	0.000134	0.00225	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CDK4—melanoma	0.000133	0.00224	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—NFKB1—melanoma	0.000132	0.00222	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—BCL2—melanoma	0.000131	0.00221	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ACER3—melanoma	0.000131	0.00221	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—ICAM1—melanoma	0.00013	0.0022	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NOS2—melanoma	0.000129	0.00218	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—melanoma	0.000128	0.00215	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CD4—melanoma	0.000126	0.00212	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IFNG—melanoma	0.000125	0.00211	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MYO7A—melanoma	0.000124	0.00209	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.000121	0.00204	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—UGT2B10—melanoma	0.00012	0.00202	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000118	0.00199	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN1B—melanoma	0.000118	0.00199	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.000118	0.00199	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000118	0.00199	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—RB1—melanoma	0.000116	0.00195	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—HRAS—melanoma	0.000115	0.00194	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.000114	0.00191	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CCND1—melanoma	0.000113	0.0019	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HS3ST5—melanoma	0.000112	0.00188	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000111	0.00187	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000111	0.00186	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.00011	0.00185	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN1A—melanoma	0.000109	0.00184	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000109	0.00183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.000107	0.0018	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HS3ST5—melanoma	0.000106	0.00178	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.000105	0.00176	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—NFKB1—melanoma	0.000104	0.00176	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACER3—melanoma	0.000104	0.00175	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.000103	0.00173	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TNF—melanoma	0.000102	0.00172	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000101	0.0017	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IFNG—melanoma	9.92e-05	0.00167	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—NRAS—melanoma	9.72e-05	0.00164	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	9.58e-05	0.00161	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—UGT2B10—melanoma	9.52e-05	0.0016	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	9.4e-05	0.00158	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CXCL8—melanoma	9.23e-05	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—melanoma	9.1e-05	0.00153	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	9.06e-05	0.00153	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—MYC—melanoma	9.05e-05	0.00152	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CDKN1B—melanoma	9.01e-05	0.00152	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	8.98e-05	0.00151	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HS3ST5—melanoma	8.85e-05	0.00149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CASP3—melanoma	8.83e-05	0.00149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL2—melanoma	8.82e-05	0.00149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CCND1—melanoma	8.6e-05	0.00145	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—APC—melanoma	8.53e-05	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLCB4—melanoma	8.45e-05	0.00142	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—melanoma	8.43e-05	0.00142	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—KRAS—melanoma	8.36e-05	0.00141	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MMP9—melanoma	8.35e-05	0.00141	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—FASN—melanoma	8.29e-05	0.0014	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—melanoma	8.26e-05	0.00139	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—melanoma	8.12e-05	0.00137	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC6A11—melanoma	7.95e-05	0.00134	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIP4K2A—melanoma	7.95e-05	0.00134	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	7.94e-05	0.00134	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	7.81e-05	0.00131	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTAP—melanoma	7.73e-05	0.0013	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	7.55e-05	0.00127	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	7.54e-05	0.00127	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CUL3—melanoma	7.53e-05	0.00127	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TRRAP—melanoma	7.53e-05	0.00127	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKR1B10—melanoma	7.33e-05	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	7.18e-05	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	7.12e-05	0.0012	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—HRAS—melanoma	7.11e-05	0.0012	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MAPK3—melanoma	7.09e-05	0.00119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MYC—melanoma	6.9e-05	0.00116	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PHGDH—melanoma	6.89e-05	0.00116	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LUM—melanoma	6.89e-05	0.00116	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	6.81e-05	0.00115	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HPSE—melanoma	6.76e-05	0.00114	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MAPK1—melanoma	6.75e-05	0.00114	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—EGFR—melanoma	6.74e-05	0.00114	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	6.71e-05	0.00113	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLCB4—melanoma	6.71e-05	0.00113	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CUBN—melanoma	6.63e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	6.62e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—FASN—melanoma	6.58e-05	0.00111	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—melanoma	6.55e-05	0.0011	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LUM—melanoma	6.53e-05	0.0011	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—melanoma	6.42e-05	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SDHD—melanoma	6.4e-05	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CSPG4—melanoma	6.4e-05	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—BSG—melanoma	6.4e-05	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HPSE—melanoma	6.4e-05	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC6A11—melanoma	6.31e-05	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIP4K2A—melanoma	6.31e-05	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CUBN—melanoma	6.29e-05	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GPAM—melanoma	6.2e-05	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTAP—melanoma	6.14e-05	0.00103	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	6.13e-05	0.00103	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CSPG4—melanoma	6.07e-05	0.00102	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	6.01e-05	0.00101	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6e-05	0.00101	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPS3—melanoma	5.97e-05	0.00101	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SKI—melanoma	5.88e-05	0.00099	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	5.85e-05	0.000985	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	5.79e-05	0.000976	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TP53—melanoma	5.66e-05	0.000954	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	5.66e-05	0.000953	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	5.64e-05	0.000951	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	5.62e-05	0.000946	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PHGDH—melanoma	5.47e-05	0.000921	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LUM—melanoma	5.47e-05	0.000921	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HPSE—melanoma	5.36e-05	0.000903	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLA2G6—melanoma	5.27e-05	0.000888	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CUBN—melanoma	5.26e-05	0.000887	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—melanoma	5.18e-05	0.000873	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	5.1e-05	0.000859	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SDHD—melanoma	5.08e-05	0.000856	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CSPG4—melanoma	5.08e-05	0.000856	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—BSG—melanoma	5.08e-05	0.000856	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GPAM—melanoma	4.92e-05	0.000829	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HDAC6—melanoma	4.85e-05	0.000818	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	4.82e-05	0.000812	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—VCAN—melanoma	4.74e-05	0.000798	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	4.69e-05	0.00079	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NPPA—melanoma	4.6e-05	0.000775	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	4.59e-05	0.000773	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	4.59e-05	0.000773	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—VCAN—melanoma	4.49e-05	0.000756	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.48e-05	0.000755	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—WNT5A—melanoma	4.46e-05	0.000751	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	4.37e-05	0.000736	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	4.33e-05	0.00073	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.33e-05	0.000729	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLA2G6—melanoma	4.19e-05	0.000705	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP17A1—melanoma	4e-05	0.000673	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.98e-05	0.000671	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.94e-05	0.000664	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	3.89e-05	0.000656	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.85e-05	0.000649	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GNA11—melanoma	3.77e-05	0.000636	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—VCAN—melanoma	3.76e-05	0.000634	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—FASN—melanoma	3.69e-05	0.000622	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC5A5—melanoma	3.63e-05	0.000612	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GAB2—melanoma	3.58e-05	0.000603	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.56e-05	0.0006	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CD44—melanoma	3.51e-05	0.000591	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GNAQ—melanoma	3.51e-05	0.000591	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FASN—melanoma	3.5e-05	0.00059	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.44e-05	0.000579	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.44e-05	0.000579	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.4e-05	0.000574	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP1B1—melanoma	3.36e-05	0.000567	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FOXO4—melanoma	3.36e-05	0.000567	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CXCR4—melanoma	3.36e-05	0.000567	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HDAC2—melanoma	3.36e-05	0.000567	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD44—melanoma	3.33e-05	0.00056	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.25e-05	0.000548	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP17A1—melanoma	3.17e-05	0.000535	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.13e-05	0.000527	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	3.09e-05	0.00052	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT3—melanoma	3.07e-05	0.000517	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GNA11—melanoma	3e-05	0.000505	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.97e-05	0.0005	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FASN—melanoma	2.93e-05	0.000494	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC5A5—melanoma	2.88e-05	0.000486	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GNAQ—melanoma	2.79e-05	0.000469	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CD44—melanoma	2.79e-05	0.000469	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCB1—melanoma	2.77e-05	0.000467	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.73e-05	0.00046	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERBB4—melanoma	2.71e-05	0.000457	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN2B—melanoma	2.69e-05	0.000453	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP1B1—melanoma	2.67e-05	0.00045	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD86—melanoma	2.6e-05	0.000438	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PRKCA—melanoma	2.55e-05	0.00043	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ERCC2—melanoma	2.53e-05	0.000426	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGF1—melanoma	2.52e-05	0.000425	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PDGFRA—melanoma	2.44e-05	0.000411	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRKCA—melanoma	2.42e-05	0.000407	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERCC2—melanoma	2.4e-05	0.000404	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAP2K2—melanoma	2.36e-05	0.000398	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.36e-05	0.000397	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TERT—melanoma	2.25e-05	0.000379	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HLA-A—melanoma	2.25e-05	0.000379	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RAC1—melanoma	2.24e-05	0.000377	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCB1—melanoma	2.2e-05	0.00037	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HIF1A—melanoma	2.15e-05	0.000362	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.09e-05	0.000353	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PRKCA—melanoma	2.02e-05	0.000341	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ERCC2—melanoma	2.01e-05	0.000338	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CG—melanoma	2e-05	0.000336	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS2—melanoma	1.95e-05	0.000329	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOTCH1—melanoma	1.94e-05	0.000326	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARG—melanoma	1.93e-05	0.000325	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD80—melanoma	1.9e-05	0.000319	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KIT—melanoma	1.89e-05	0.000319	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APC—melanoma	1.89e-05	0.000319	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EGF—melanoma	1.87e-05	0.000315	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—BRAF—melanoma	1.78e-05	0.0003	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CD—melanoma	1.76e-05	0.000296	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALB—melanoma	1.73e-05	0.000292	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAP2K1—melanoma	1.68e-05	0.000282	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CD—melanoma	1.66e-05	0.00028	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.66e-05	0.00028	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGF2—melanoma	1.59e-05	0.000268	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CG—melanoma	1.59e-05	0.000267	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CB—melanoma	1.53e-05	0.000258	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARG—melanoma	1.53e-05	0.000258	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—melanoma	1.52e-05	0.000255	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MDM2—melanoma	1.49e-05	0.000251	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERBB2—melanoma	1.47e-05	0.000248	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CB—melanoma	1.45e-05	0.000244	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD4—melanoma	1.45e-05	0.000244	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CD—melanoma	1.39e-05	0.000235	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALB—melanoma	1.38e-05	0.000232	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN1B—melanoma	1.36e-05	0.000229	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTEN—melanoma	1.32e-05	0.000223	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CTNNB1—melanoma	1.29e-05	0.000217	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN1A—melanoma	1.26e-05	0.000212	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PTEN—melanoma	1.25e-05	0.000211	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CB—melanoma	1.21e-05	0.000205	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT3—melanoma	1.12e-05	0.000189	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NRAS—melanoma	1.12e-05	0.000188	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAPK3—melanoma	1.07e-05	0.00018	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PTEN—melanoma	1.05e-05	0.000177	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MYC—melanoma	1.04e-05	0.000175	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAPK1—melanoma	1.02e-05	0.000172	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EGFR—melanoma	1.02e-05	0.000172	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KRAS—melanoma	9.63e-06	0.000162	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CA—melanoma	9.33e-06	0.000157	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CA—melanoma	8.84e-06	0.000149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HRAS—melanoma	8.18e-06	0.000138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—melanoma	7.83e-06	0.000132	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKT1—melanoma	7.62e-06	0.000128	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CA—melanoma	7.41e-06	0.000125	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT1—melanoma	7.22e-06	0.000122	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKT1—melanoma	6.05e-06	0.000102	CbGpPWpGaD
